Pérez, M.; Lozano, J.J.; Ingelmo-Torres, M.; Domenech, M.; Fernández Ramón, C.; Witjes, J.A.; van der Heijden, A.G.; Requena, M.J.; Coy, A.; Calderon, R.;
et al. Biomarker-Based Nomogram to Predict Neoadjuvant Chemotherapy Response in Muscle-Invasive Bladder Cancer. Biomedicines 2025, 13, 740.
https://doi.org/10.3390/biomedicines13030740
AMA Style
Pérez M, Lozano JJ, Ingelmo-Torres M, Domenech M, Fernández Ramón C, Witjes JA, van der Heijden AG, Requena MJ, Coy A, Calderon R,
et al. Biomarker-Based Nomogram to Predict Neoadjuvant Chemotherapy Response in Muscle-Invasive Bladder Cancer. Biomedicines. 2025; 13(3):740.
https://doi.org/10.3390/biomedicines13030740
Chicago/Turabian Style
Pérez, Meritxell, Juan José Lozano, Mercedes Ingelmo-Torres, Montserrat Domenech, Caterina Fernández Ramón, J. Alfred Witjes, Antoine G. van der Heijden, Maria José Requena, Antonio Coy, Ricard Calderon,
and et al. 2025. "Biomarker-Based Nomogram to Predict Neoadjuvant Chemotherapy Response in Muscle-Invasive Bladder Cancer" Biomedicines 13, no. 3: 740.
https://doi.org/10.3390/biomedicines13030740
APA Style
Pérez, M., Lozano, J. J., Ingelmo-Torres, M., Domenech, M., Fernández Ramón, C., Witjes, J. A., van der Heijden, A. G., Requena, M. J., Coy, A., Calderon, R., Mellado, B., Alcaraz, A., Vilaseca, A., & Ribal, M. J.
(2025). Biomarker-Based Nomogram to Predict Neoadjuvant Chemotherapy Response in Muscle-Invasive Bladder Cancer. Biomedicines, 13(3), 740.
https://doi.org/10.3390/biomedicines13030740
